Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

High-dimensional CyTOF analysis of dengue virus-infected human DCs reveals distinct viral signatures.

Hamlin RE, Rahman A, Pak TR, Maringer K, Mena I, Bernal-Rubio D, Potla U, Maestre AM, Fredericks AC, Amir ED, Kasarskis A, Ramos I, Merad M, Fernandez-Sesma A.

JCI Insight. 2017 Jul 6;2(13). pii: 92424. doi: 10.1172/jci.insight.92424. [Epub ahead of print]

2.

A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.

Wang BX, Wei L, Kotra LP, Brown EG, Fish EN.

Viruses. 2017 May 12;9(5). pii: E107. doi: 10.3390/v9050107.

3.

Influenza virus exploits tunneling nanotubes for cell-to-cell spread.

Kumar A, Kim JH, Ranjan P, Metcalfe MG, Cao W, Mishina M, Gangappa S, Guo Z, Boyden ES, Zaki S, York I, García-Sastre A, Shaw M, Sambhara S.

Sci Rep. 2017 Jan 6;7:40360. doi: 10.1038/srep40360.

4.

G45R mutation in the nonstructural protein 1 of A/Puerto Rico/8/1934 (H1N1) enhances viral replication independent of dsRNA-binding activity and type I interferon biology.

Kaewborisuth C, Zanin M, Häcker H, Webby RJ, Lekcharoensuk P.

Virol J. 2016 Jul 12;13:127. doi: 10.1186/s12985-016-0585-4.

5.

Networks of Host Factors that Interact with NS1 Protein of Influenza A Virus.

Thulasi Raman SN, Zhou Y.

Front Microbiol. 2016 May 4;7:654. doi: 10.3389/fmicb.2016.00654. eCollection 2016.

6.

Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas.

Stucker KM, Schobel SA, Olsen RJ, Hodges HL, Lin X, Halpin RA, Fedorova N, Stockwell TB, Tovchigrechko A, Das SR, Wentworth DE, Musser JM.

Euro Surveill. 2015 May 7;20(18). pii: 21122.

7.

Proteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes infected with influenza A virus.

Kebaabetswe LP, Haick AK, Gritsenko MA, Fillmore TL, Chu RK, Purvine SO, Webb-Robertson BJ, Matzke MM, Smith RD, Waters KM, Metz TO, Miura TA.

Virology. 2015 Sep;483:96-107. doi: 10.1016/j.virol.2015.03.045. Epub 2015 May 15.

8.

Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.

Noriega VM, Haye KK, Kraus TA, Kowalsky SR, Ge Y, Moran TM, Tortorella D.

J Virol. 2014 Aug;88(16):9391-405. doi: 10.1128/JVI.00934-14. Epub 2014 Jun 11.

9.

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.

J Virol. 2014 Aug;88(15):8375-85. doi: 10.1128/JVI.00126-14. Epub 2014 May 14.

10.

Influenza viruses and mRNA splicing: doing more with less.

Dubois J, Terrier O, Rosa-Calatrava M.

MBio. 2014 May 13;5(3):e00070-14. doi: 10.1128/mBio.00070-14. Review.

11.

Enhanced viral replication and modulated innate immune responses in infant airway epithelium following H1N1 infection.

Clay CC, Reader JR, Gerriets JE, Wang TT, Harrod KS, Miller LA.

J Virol. 2014 Jul;88(13):7412-25. doi: 10.1128/JVI.00188-14. Epub 2014 Apr 16.

12.

Model of influenza A virus infection: dynamics of viral antagonism and innate immune response.

Fribourg M, Hartmann B, Schmolke M, Marjanovic N, Albrecht RA, García-Sastre A, Sealfon SC, Jayaprakash C, Hayot F.

J Theor Biol. 2014 Jun 21;351:47-57. doi: 10.1016/j.jtbi.2014.02.029. Epub 2014 Mar 2.

13.

The NS segment of H5N1 avian influenza viruses (AIV) enhances the virulence of an H7N1 AIV in chickens.

Vergara-Alert J, Busquets N, Ballester M, Chaves AJ, Rivas R, Dolz R, Wang Z, Pleschka S, Majó N, Rodríguez F, Darji A.

Vet Res. 2014 Jan 25;45:7. doi: 10.1186/1297-9716-45-7.

14.

Antiviral responses by Swine primary bronchoepithelial cells are limited compared to human bronchoepithelial cells following influenza virus infection.

Hauser MJ, Dlugolenski D, Culhane MR, Wentworth DE, Tompkins SM, Tripp RA.

PLoS One. 2013 Jul 10;8(7):e70251. doi: 10.1371/journal.pone.0070251. Print 2013.

15.

Alphacoronavirus protein 7 modulates host innate immune response.

Cruz JL, Becares M, Sola I, Oliveros JC, Enjuanes L, Zúñiga S.

J Virol. 2013 Sep;87(17):9754-67. doi: 10.1128/JVI.01032-13. Epub 2013 Jul 3.

16.

Overcoming NS1-mediated immune antagonism involves both interferon-dependent and independent mechanisms.

Thakar J, Schmid S, Duke JL, García-Sastre A, Kleinstein SH.

J Interferon Cytokine Res. 2013 Nov;33(11):700-8. doi: 10.1089/jir.2012.0113. Epub 2013 Jun 17.

17.

The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors.

Versteeg GA, Rajsbaum R, Sánchez-Aparicio MT, Maestre AM, Valdiviezo J, Shi M, Inn KS, Fernandez-Sesma A, Jung J, García-Sastre A.

Immunity. 2013 Feb 21;38(2):384-98. doi: 10.1016/j.immuni.2012.11.013.

18.

Innate immunity to H5N1 influenza viruses in humans.

Ramos I, Fernandez-Sesma A.

Viruses. 2012 Dec;4(12):3363-88. Review.

19.

Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells.

Ramos I, Carnero E, Bernal-Rubio D, Seibert CW, Westera L, García-Sastre A, Fernandez-Sesma A.

J Virol. 2013 Mar;87(5):2430-40. doi: 10.1128/JVI.02247-12. Epub 2012 Dec 19.

20.

Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein.

Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villán E, García-Sastre A, Gack MU.

PLoS Pathog. 2012;8(11):e1003059. doi: 10.1371/journal.ppat.1003059. Epub 2012 Nov 29.

Supplemental Content

Support Center